Issue Date: December 24, 2012
Regulating Drug Compounders
On the heels of a multistate outbreak of fungal meningitis linked to a Massachusetts-based compounding pharmacy that produced injectable steroids, the Food & Drug Administration is pushing for new legislation that would strengthen its oversight of such facilities.
At a meeting with state pharmacy regulators last week, FDA Commissioner Margaret A. Hamburg proposed a system that would require large compounding pharmacies to register with FDA and undergo routine inspections by the agency. Compounding pharmacies are . . .
To view the rest of this content, please log in with your ACS ID.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society